Market revenue in 2024 | USD 274.8 million |
Market revenue in 2030 | USD 460.4 million |
Growth rate | 9% (CAGR from 2025 to 2030) |
Largest segment | Psoriasis |
Fastest growing segment | Psoriasis |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Acne, Psoriasis, Rosacea, Alopecia |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatological drugs market will help companies and investors design strategic landscapes.
Psoriasis was the largest segment with a revenue share of 39.23% in 2024. Horizon Databook has segmented the Sweden dermatological drugs market based on acne, psoriasis, rosacea, alopecia covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden's dermatological drugs market demonstrates steady growth, supported by an increasing prevalence of skin conditions, including eczema, acne, and skin cancer. The demand for aesthetic dermatology treatments, such as anti-aging products, also contributes to market expansion. The country’s robust healthcare system and advanced pharmaceutical infrastructure provide a strong foundation for drug distribution and accessibility.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden dermatological drugs market , including forecasts for subscribers. This country databook contains high-level insights into Sweden dermatological drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account